Clinical Trial Update: Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial comparing the combination of deferasirox and deferiprone to the combination of deferiprone and deferoxamine (Desferal) for iron overl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta Thalassemia Major
• Iron Overload
• Sickle Cell Disease

Drugs mentioned

• Deferasirox (Deferasirox)
• Deferiprone (deferiprone)
• Desferal (Deferoxamine Mesylate)

Snippet

Sponsor: Ain Shams University | Conditions: Beta-thalassemia Major, Sickle Cell Disease | Phase 2, Phase 3 | Status: UNKNOWN